中國船舶(600150.SH):2021年全年共承接民品船舶訂單132艘/1211.17萬載重噸 噸位數同比增長91%
格隆匯3月8日丨 中國船舶(600150.SH)公佈,2021年,公司緊扣航運市場脈搏,搶抓市場機遇,創新經營工作體制機制,堅持整體營銷,注重訂單質量,強化風險管控,實現新船訂單大幅增長和船價顯著上漲。公司2021年全年共承接民品船舶訂單132艘/1211.17萬載重噸,噸位數同比增長91%。根據中國船舶工業行業協會數據,公司全年民品船舶訂單約佔全球市場訂單的9.72%(以載重噸計)。
此外,公司2021年全年完成承接柴油機732台/615萬馬力,馬力數同比增長30%;承接修船訂單金額24.27億元,同比增長5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.